Prospective studies are needed to demonstrate any modifications of the JAK2/STAT3 pathway following thrombocytopenia and to determine whether the JAK2/STAT3 pathway may contribute to hyperprogression. This evidence concerns the gene STAT3 and Thrombocytopenia.